Top

Diabetologia

Published in:

01-01-2014 | Article

Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function

Authors: Raquel Ferrer-Lorente, Maria Teresa Bejar, Monica Tous, Gemma Vilahur, Lina Badimon

Published in: Diabetologia | Issue 1/2014

Abstract

Aims/hypothesis

Autologous progenitor cells represent a promising option for regenerative cell-based therapies. Nevertheless, it has been shown that ageing and cardiovascular risk factors such as diabetes affect circulating endothelial and bone marrow-derived progenitor cells, limiting their therapeutic potential. However, their impact on other stem cell populations remains unclear. We therefore investigated the effects of diabetes on adipose-derived stem cells (ASCs) and whether these effects might limit the therapeutic potential of autologous ASCs.

Methods

A systems biology approach was used to analyse the expression of genes related to stem cell identification in subcutaneous adipose tissue (SAT), the stromal vascular fraction and isolated ASCs from Zucker diabetic fatty rats and their non-diabetic controls. An additional model of type 2 diabetes without obesity was also investigated. Bioinformatic approaches were used to investigate the biological significance of these changes. In addition, functional studies on cell viability and differentiation potential were performed.

Results

Widespread downregulation of mesenchymal stem cell markers was observed in SAT of diabetic rats. Gene expression and in silico analysis revealed a significant effect on molecules involved in the maintenance of pluripotency and self-renewal, and on the alteration of main signalling pathways important for stem cell maintenance. The viability and differentiation potential of ASCs from diabetic rats was impaired in in vitro models and in in vivo angiogenesis.

Conclusions/interpretation

The impact of type 2 diabetes on ASCs might compromise the efficiency of spontaneous self-repair and direct autologous stem cell therapy.

Available only for authorised users

Pittenger MF, Martin BJ (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:9–20CrossRefPubMed

Van der Bogt KEA, Sheikh AY, Schrepfer S et al (2008) Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 118:S121–S129CrossRefPubMed

Kamihata H, Matsubara H, Nishiue T et al (2001) Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104:1046–1052CrossRefPubMed

Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701–705CrossRefPubMed

Cleland JGF, Fremantle N, Coletta AP, Clark AL (2006) Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail 8:105–110CrossRefPubMed

Gimble JM, Guilak F, Bunnell BA (2010) Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 1:19CrossRefPubMed

Tepper OM, Galiano RD, Capla JM et al (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781–2786CrossRefPubMed

Li TS, Furutani A, Takahashi M et al (2006) Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats. Am J Physiol Heart Circ Physiol 290:H1362–H1369CrossRefPubMed

Fadini GP, Sartore S, Schiavon M et al (2006) Diabetes impairs progenitor cell mobilization after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 49:3075–3084CrossRefPubMed

10.

Sharpless NE, DePinho RA (2007) How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 8:703–713CrossRefPubMed

11.

Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV (1966) Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morpholog 16:381–390

12.

Dominici M, Le Blanc K, Mueller E et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317CrossRefPubMed

13.

Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739–2749CrossRefPubMed

14.

Da Silva ML, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204–2213CrossRef

15.

Zuk PA, Zhu M, Ashjian P et al (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279–4295CrossRefPubMed

16.

Gimble JM, Katz AJ, Bunnell BA (2007) Adipose-derived stem cells for regenerative medicine. Circ Res 100:1249–1260CrossRefPubMed

17.

Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z (2008) Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct 26:664–675CrossRefPubMed

18.

Schäffler A, Büchler C (2007) Concise review: adipose tissue-derived stromal cells—basic and clinical implications for novel cell-based therapies. Stem Cells 25:818–827CrossRefPubMed

19.

Madonna R, Geng YJ, de Caterina R (2009) Adipose tissue derived stem cells: characterization and potential for cardiovascular repair. Arterioscler Thromb Vasc Biol 29:1723–1729CrossRefPubMed

20.

Mizuno H, Tobita M, Uysal AC (2012) Adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 30:804–810CrossRefPubMed

21.

Clark JB, Palmer CJ, Shaw WN (1983) The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 173:68–75CrossRefPubMed

22.

Masiello P, Broca C, Gross R et al (1998) Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47:224–229CrossRefPubMed

23.

Golzelniak K, Janke J, Engeli S, Sharma AM (2001) Validation of endogenous controls for gene expression studies in human adipocytes and preadipocytes. Horm Metab Res 33:625–627CrossRef

24.

Li YM, Schilling T, Benisch P et al (2007) Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun 363:209–215CrossRefPubMed

25.

Nichols J, Zevnik B, Anastassiadis K et al (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379–391CrossRefPubMed

26.

Boiani M, Schöler HR (2005) Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 6:872–884CrossRefPubMed

27.

Riekstina U, Cakstina I, Parfejevs V et al (2009) Embryonic stem cell markers expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev Rep 5:378–386CrossRef

28.

Park IH, Zhao R, West JA et al (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141–146CrossRefPubMed

29.

Radtke F, Raj K (2003) The role of Notch in tumorigenesis: oncogene or tumor suppressor? Nat Rev Cancer 3:765–767

30.

Nichols AM, Pan Y, Herreman A et al (2004) Notch pathway is dispensable for adypocite specification. Genesis 40:40–44CrossRefPubMed

31.

Garcés C, Ruiz-Hidalgo MJ, Font de Mora J et al (1997) Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J Biol Chem 272:29729–29734CrossRefPubMed

32.

Ugarte F, Ryser M, Thieme S et al (2009) Notch signalling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells. Exp Hematol 37:867–875CrossRefPubMed

33.

Huang Y, Yang X, Wu Y et al (2010) γ-Secretase inhibitor induces adipogenesis of adipose-derived stem cells by notch regulation of Notch and PPARγ. Cell Prolif 43:147–156CrossRefPubMed

34.

Laudes M (2011) Role of Wnt signalling in the determination of human mesenchymal stem cells into preadipocytes. J Mol Endocrinol 46:65–72

35.

Lanner F, Rossant J (2010) The role of FGF/Erk signalling in pluripotent cells. Development 137:3351–3360CrossRefPubMed

36.

Zaragosi LE, Ailhaud G, Dani C (2006) Autocrine fibroblast growth factor 2 signalling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 24:2412–2419CrossRefPubMed

37.

Xiao L, Sobue T, Esliger A et al (2010) Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells. Bone 47:360–370CrossRefPubMed

38.

Kume S, Kato S, Yamagishi S et al (2005) Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res 20:1647–1658CrossRefPubMed

39.

Van Tienen FHJ, van der Kallen CJH, Lindsey PJ, Wanders RJ, van Grevenbroek MM, Smeets HJM (2011) Preadypocytes of type 2 diabetes subjects display an intrinsic gene expression profile of decreased differentiation capacity. Int J Obes 35:1154–1164CrossRef

40.

Gopalakrishnan V, Vignesh RC, Arunakaran J, Aruldhas MM, Srinivasan N (2006) Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol 84:93–101CrossRefPubMed

41.

Aguiari P, Leo S, Zavan B et al (2008) High glucose induces adipogenic differentiation of muscle-derived stem cells. PNAS 105:1226–1231CrossRefPubMed

42.

Bicknell R, Harris AL (2004) Novel angiogenic signalling pathways and vascular targets. Annu Rev Pharmacol Toxicol 44:219–238CrossRefPubMed

43.

Zerlin M, Julius MA, Kitajewski J (2008) Wnt/Frizzled signalling in angiogenesis. Angiogenesis 1:63–69CrossRef

44.

Phng LK, Gerhardt H (2009) Angiogenesis: a team effort coordinated by Notch. Dev Cell 16:196–208CrossRefPubMed

45.

Limbourg A, Ploom M, Elligsen D et al (2007) Notch ligand delta-like 1 is essential for postnatal arteriogenesis. Circ Res 100:363–371CrossRefPubMed

46.

Benedito R, Roca C, Sörensen I et al (2009) The Notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137:1124–1135CrossRefPubMed

47.

Dejana E (2010) The role of Wnt signalling in physiological and pathological angiogenesis. Circ Res 107:943–952CrossRefPubMed

48.

Zhang B, Ma J (2010) Wnt pathway antagonists and angiogenesis. Protein Cell 1:898–906CrossRefPubMed

49.

Chang YJ, Shih DT, Tseng CP, Hsieh TB, Lee DC, Hwang SM (2006) Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 24:679–685CrossRefPubMed

50.

Scheller EL, Song J, Dishowitz MI, Soki FN, Hankenson KD, Krebsbach PH (2010) Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells 28:1071–1080CrossRefPubMed

Title: Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function
Authors: Raquel Ferrer-Lorente
Maria Teresa Bejar
Monica Tous
Gemma Vilahur
Lina Badimon
Publication date: 01-01-2014
Publisher: Springer Berlin Heidelberg
Published in: Diabetologia / Issue 1/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-013-3081-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Please log in to get access to this content

Other articles of this Issue 1/2014

Association between maternal folate concentrations during pregnancy and insulin resistance in Indian children

Incidence of type 1 diabetes in Norway among children aged 0–14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry

Lifestyle factors and mortality risk in individuals with diabetes mellitus: are the associations different from those in individuals without diabetes?

SMAD2 disruption in mouse pancreatic beta cells leads to islet hyperplasia and impaired insulin secretion due to the attenuation of ATP-sensitive K+ channel activity

NRF2 plays a protective role in diabetic retinopathy in mice

Nitric oxide vs insulin secretion, action and clearance

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials